Related references
Note: Only part of the references are listed.The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation
Guifang Cai et al.
IMMUNOLOGICAL REVIEWS (2009)
B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
Andrew C. Vendel et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction
Xikui Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Herpesvirus Entry Mediator-Ig Treatment during Immunization Aggravates Rheumatoid Arthritis in the Collagen-Induced Arthritis Model
Matthias Pierer et al.
JOURNAL OF IMMUNOLOGY (2009)
B and T Lymphocyte Attenuator Tempers Early Infection Immunity
Yonglian Sun et al.
JOURNAL OF IMMUNOLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Unconventional ligand activation of herpesvirus entry mediator signals cell survival
Timothy C. Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator
Yoshihiro Oya et al.
ARTHRITIS AND RHEUMATISM (2008)
Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis
M. Okano et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections
Sang-Jun Ha et al.
IMMUNOLOGICAL REVIEWS (2008)
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
Karl S. Peggs et al.
IMMUNOLOGICAL REVIEWS (2008)
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
Carl F. Ware
IMMUNOLOGICAL REVIEWS (2008)
A crucial role for HVEM and BTLA in preventing intestinal inflammation
Marcos W. Steinberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen
Daniel E. Speiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malarial
Bernd Lepenies et al.
JOURNAL OF IMMUNOLOGY (2007)
Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides
James N. Kochenderfer et al.
CLINICAL IMMUNOLOGY (2007)
Development of TLR9 agonists for cancer therapy
Arthur M. Krieg
JOURNAL OF CLINICAL INVESTIGATION (2007)
B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation
Carsten Krieg et al.
NATURE IMMUNOLOGY (2007)
Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA
Maya Gavrieli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells
Noriko Otsuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation
Christine Deppong et al.
JOURNAL OF IMMUNOLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs
Jens M. Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2006)
Balancing co-stimulation and inhibition with BTLA and HVEM
Kenneth M. Murphy et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells
C Krieg et al.
JOURNAL OF IMMUNOLOGY (2005)
The role of tumor stroma in the interaction between tumor and immune system
T Blankenstein
CURRENT OPINION IN IMMUNOLOGY (2005)
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells
MA Hurchla et al.
JOURNAL OF IMMUNOLOGY (2005)
The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses
Y Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance
A Zippelius et al.
CANCER RESEARCH (2004)
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
P Han et al.
JOURNAL OF IMMUNOLOGY (2004)
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity
RT Costello et al.
LEUKEMIA (2003)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
CpG are efficient Adjuvants for specific CTL induction against tumor antigen-derived peptide
I Miconnet et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and function of NK cell receptors in CD8+ T cells
CW McMahon et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor
Y Morel et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
